Defects of DNA mismatch repair in human prostate cancer

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4112-4121

  Chen, Yian ^a   Wang, Jiansong ^b,c   Fraig, Mostafa M ^b   Metcalf, John ^b   Turner, William R ^b   Bissada, Nabil K ^b   Watson, Dennis K ^a,b   Schweinfest, Clifford W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Second Affiliated Hospital of Kunming Medical College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASE MISPAIRING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; GENE MUTATION; GENETIC STABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; STOCHASTIC MODEL;

ADENOSINE TRIPHOSPHATASES; BASE PAIR MISMATCH; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035872438     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Cancer statistics 2000
2. Precise microdissection of human prostate cancers reveals genotypic heterogeneity
3. Mechanisms and biological effects of mismatch repair
4. Escherichia coli mutS-encoded protein binds to mismatched DNA base pairs
5. DNA mismatch correction in a defined system
6. Initiation of methyl-directed mismatch repair
7. Mismatch repair in replication fidelity, genetic recombination, and cancer biology
8. Structural basis for MutH activation in E. coli mismatch repair and relationship of MutH restriction endonucleases
9. Crystal structure and ATPase activity of MutL: Implications for DNA repair and mutagenesis
10. The Escherichia coli MutL protein physically interacts with MutH and stimulates the MutH-associated endonuclease activity
11. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
12. Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene
13. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer
14. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
15. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6
16. Binding of insertion/deletion DNA mismatches by the heterocimer of yeast mismatch repair proteins MSH2 and MSH3
17. Redundancy of Saccharomyces cerevisiae MSH2 MSH6 in MSH2-dependent mismatch repair
18. Identification of hMutLβ a heterodimer of hMLH1 and hPMS1
19. Mutations of the mutS homologue in hereditary nonpolyposis colorectal cancer
20. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colon cancer
21. Mutation of a mutL homologue in hereditary colon cancer
22. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred
23. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences
24. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients
25. Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer
26. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations
27. Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing
28. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features
29. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity
30. Mutational analysis of mismatch repair genes, hMLH1 and hMSH2, in sporadic endometrial carcinomas with microsatellite instability
31. Microsatellite instability and alterations of the hMSH2 gene in human ovarian cancer
32. Clues to the pathogenesis of familial colorectal cancer
33. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients
34. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial, and hereditary colorectal cancer
35. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
36. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients
37. Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis
38. Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathological implications and prognosis
39. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer
40. Microsatellite instability in human solid tumors
41. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
42. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
43. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
44. Frameshift mutator mutations
45. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors
46. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype
47. PTEN, a putative protein tyrosine phosphatase gene, mutated in human brain, breast, and prostate cancer
48. Microsatellite instability in prostate cancer
49. Genomic instability of microsatellite repeats in prostate cancer: Relationship to clinicopathological variables
50. Allelic imbalance and microsatellite instability in prostate adenocarcinoma
51. High frequency of mutator phenotype in human prostatic adenocarcinoma
52. Microsatellite instability and loss of heterozygosity in prostatic carcinomas: Comparison of primary tumors and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases
53. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer
54. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
55. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1
56. A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype
57. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines
58. Intraductal dysplasia: A premalignant lesion of the prostate
59. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: Prognostic influences of stage, tumor volume, grade, and margins of resection
60. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
61. Genetic mapping of a locus predisposing to human colorectal cancer
62. Microsatellite instability in cancer of the proximal colon
63. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP
64. Isolation of a human prostate carcinoma cell line (DU 145)
65. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer
66. Role of the basal cells in premalignant changes of the human prostate: A stem cell concept for the development of prostate cancer
67. Differentiation pathways and histogenetic aspects of normal and abnormal prostate growth: A stem cell model
68. kipI in normal, hyperplastic, and neoplastic cells
69. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
70. c-met proto-oncogene expression in benign and malignant human prostate tissues
71. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers
72. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer
73. Cycling activity of benign prostatic epithelial cells during long-term androgen blockade: Evidence for self-renewal of luminal cells
74. Eukaryotic DNA mismatch repair
75. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene
76. A hPMS2 mutant cell line is defective in strand-specific mismatch repair
77. Single gene complementation of the hPMS2 defect in HEC-1-A endometrial carcinoma cells
78. Multiple mutations and frameshifts are the hallmark of defective hPMS2 in pZ189-transfected human tumor cells
79. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
80. MSH2-deficient mice are viable and susceptible to lymphoid tumors
81. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility
82. Tumor susceptibility and spontaneous mutation in mice deficient in mlh1, Pms1, and Pms2 DNA mismatch repair
83. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over
84. Meiotic pachytene arrest in MLH1-deficient mice
85. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis
86. MLH3: A DNA mismatch repair gene associated with mammalian microsatellite instability
87. Different mutator phenotypes in Mlh1-versus Pms2-deficient mice